Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review
Descriptive findings of a therapeutic signal were observed in some subjects with ASD at low doses, not associated with toxic or disruptive effects. As restrictions on psilocybin use are lifted, studies with a higher level of evidence should be conducted.
Authors
- Jaime Moreno‐Chaparro (ORCID: https://orcid.org/0000-0002-5655-3654)
- Javier Eslava‐Schmalbach (ORCID: https://orcid.org/0000-0003-1502-2918)
- Gabriela Castañeda-Millán (ORCID: https://orcid.org/0009-0005-4704-3707)
Institutions
- Universidad Nacional de Colombia (CO)
- Hospital Universitario Nacional de Colombia (CO)
Publication Details
- Journal
- Clinical Neuropharmacology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1097/wnf.0000000000000653
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00